According to new research presented yesterday at the American Heart Association's annual meeting in New Orleans, Avandia does not provide any statistically significant reduction in the buildup of plaque in coronary arteries when compared to an older generic diabetes drug. The findings could add further support to the growing movement calling for an Avandia recall, since many experts indicate that any potential benefits of the drug are outweighed by the risk, especially considering alternative According to new research presented yesterday at the American Heart Association's annual meeting in New Orleans, Avandia does not provide any statistically significant reduction in the buildup of plaque in coronary arteries when compared to an older generic diabetes drug. The findings could add further support to the growing movement calling for an Avandia recall, since many experts indicate that any potential benefits of the drug are outweighed by the risk, especially considering alternative
No comments:
Post a Comment